Does Tigecycline Cause Severe Liver Damage?
Tigecycline, an antibiotic used for complicated infections, carries warnings for liver toxicity. The FDA label notes rare cases of hepatic failure and death, including cholestatic hepatitis and worsening liver function in patients with pre-existing issues. Post-marketing reports include severe liver injury, sometimes fatal, though causality isn't always confirmed.[1]
What Do Clinical Trials and Studies Show?
In phase 3 trials, tigecycline showed elevated liver enzymes (ALT/AST >10x upper limit) in about 2-4% of patients, higher than comparators like imipenem. Serious hepatic adverse events occurred in <1%, but severe cases were linked to longer exposure or comorbidities. A 2020 meta-analysis found tigecycline increased risk of abnormal liver tests by 1.5-2x versus other antibiotics.[2][3]
Which Patients Face Higher Risk?
Those with hepatitis, cirrhosis, or alcohol-related liver disease see amplified risk. Labeling advises monitoring LFTs and avoiding use in severe hepatic impairment (Child-Pugh C). Obesity and IV administration may contribute, per case reports of acute liver failure.[1][4]
How Does It Compare to Other Antibiotics?
Tigecycline's hepatotoxicity rate exceeds vancomycin (1-2%) but matches some carbapenems. Unlike linezolid, which rarely causes severe damage, tigecycline has black-box warnings for mortality partly tied to liver events in vulnerable groups.[1][5]
What Symptoms Signal Liver Damage?
Watch for jaundice, dark urine, nausea, fatigue, or abdominal pain within days to weeks of starting. Discontinue if ALT/AST rise >5x or bilirubin doubles. Recovery often follows cessation, but some cases progress to failure needing transplant.[1][4]
Regulatory Warnings and Monitoring
FDA requires hepatic adverse reaction warnings on labeling since 2005 approval. EMA echoes this, mandating LFT checks before and during therapy. No recent recalls, but ongoing pharmacovigilance tracks rare fulminant cases.[1][6]
Sources:
[1] FDA Tigecycline Label
[2] ClinicalTrials.gov Tigecycline Studies
[3] Meta-Analysis on Tigecycline Hepatotoxicity
[4] LiverTox Database: Tigecycline
[5] IDSA Guidelines on Antibiotics
[6] EMA Tigecycline Assessment